Boots UK: Parent company decides against selling pharmacy chain

Boots’ parent company Walgreens Boots Alliance has ultimately decided not to sell the UK pharmacy chain, following months of speculation as to who could snap up the health and beauty giant.

breaking
Boots sale
Walgreens Boots Alliance: "It is in the best interests of shareholders to keep focusing on the further growth"

This concludes the company’s “strategic review” into its UK business, which reportedly saw it tabling multi-billion pound bids from private equity firms and Asda owners, the Issa brothers.

No prospective buyers were able to make an offer “that adequately reflects the high potential value” of Boots UK and the company’s No7 Beauty brand, Walgreens Boots Alliance said in an announcement today (June 28).

Read more: Could the Boots UK sale fall through?

The company cited “market instability” impacting on companies’ ability to get financial backing, which was caused by “unexpected and dramatic” changes to global financial markets since Boots and No7 were put up for sale in January.

Walgreens Boots Alliance received “significant interest from prospective buyers”, but ultimately decided it was in shareholders’ interest to keep hold of the businesses and “keep focusing on [their] further growth and profitability”.

It appears to confirm media reports that bidders were unable to match Walgreens Boots Alliance’s ambition to sell Boots UK for £7 billion.

Read more: Boots UK sale: speculation and potential market impact – where are we now?

However, both Boots and No7 have “exceeded expectations despite challenging conditions”, which further supported Walgreens Boots Alliance’s decision to keep hold of the companies, it said.

An “exciting time”

Walgreens Boots Alliance chief executive officer Rosalind Brewer said the outcome of the “thorough” strategic review signalled an “exciting time” for Boots and No7.

“The board and I remain confident that Boots and No7 Beauty Company hold strong fundamental value, and longer term, we will stay open to all opportunities to maximise shareholder value for these businesses and across our company,” she commented.

Read more: Boots owner will reportedly keep stake in chain to ease sale of UK arm

Rumours that Walgreens Boots Alliance was considering selling off Boots UK first surfaced at the end of last year, prompting media speculation as to who could decide to buy the pharmacy chain.

Since then, speculation that the sale could fall through has dogged the company, with prospective buyers reportedly dropping in and out of the running and the final bidding deadline rumoured to have been extended several times.

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Multiples

Boots recalls paracetamol over ‘incorrect’ aspirin packaging

 
• By 
 • comment

Boots has issued a recall for 120,000 packs of its own brand paracetamol due to “incorrect packaging” and called on customers to return the product for a “full refund”.

Asda pharmacy launches adult earache service to ‘reduce burden’ on NHS services

 
• By 
 • comment

Asda has launched the “UK’s first” adult earache service at over 220 of its pharmacies in England to “[reduce] the burden on NHS services”, with same day appointments available and priced at £25.